Lensar (LNSR) Cash from Operations (2019 - 2026)
Lensar's (LNSR) quarterly Cash from Operations came in at 4271000.0 in Q1 2026, up 38.44% year-on-year from 3085080.48 in Q1 2025, and down 791.1% on a QoQ basis from 618000.0 in Q4 2025.
Lensar (LNSR) Cash from Operations (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Cash from Operations data on file, last reported at 4271000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 38.44% year-over-year to 4271000.0 in Q1 2026; TTM through Mar 2026 was 12164000.0, a 211.42% decrease from a year earlier, with the FY2025 full-year figure at 14831000.0, down 551.91% from the prior year.
- Cash from Operations for Q1 2026 stood at 4271000.0, down from 618000.0 in the prior quarter.
- Over the last five years, Cash from Operations for LNSR reached as high as 3657000.0 in Q4 2024 and fell as low as 6938000.0 in Q1 2025.
- Historically, Cash from Operations has averaged 2699529.41 across 5 years, with a median of 3513000.0 in 2025.
- Across the five-year window, Cash from Operations slumped 543.84% in 2022 and soared 1030.09% in 2024, its largest moves.
- Year by year, Cash from Operations stood at 4758000.0 in 2022, then surged by 89.91% to 480000.0 in 2023, then jumped by 861.88% to 3657000.0 in 2024, then plunged by 83.1% to 618000.0 in 2025, then plunged by 791.1% to 4271000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 4271000.0 in Q1 2026, 618000.0 in Q4 2025, and 3513000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 43.80 Mn |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 290.00 Mn |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | 525.60 Mn |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 220.10 Mn |
| 10 | Lensar | 66.89 Mn | 55.79 Mn | 6.38 Mn | -4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.27 Mn |
| Mar 31, 2026 | -4.27 Mn |
| Dec 31, 2025 | 618,000.00 |
| Dec 31, 2025 | 618,000.00 |
| Sep 30, 2025 | -3.51 Mn |
| Sep 30, 2025 | -3.51 Mn |
| Jun 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -5.00 Mn |
| Mar 31, 2025 | -6.94 Mn |
| Mar 31, 2025 | -6.94 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | -3.78 Mn |
| Jun 30, 2024 | -3.78 Mn |
| Mar 31, 2024 | -5.31 Mn |
| Mar 31, 2024 | -5.31 Mn |
| Dec 31, 2023 | -480,000.00 |
| Dec 31, 2023 | -480,000.00 |